Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
Investigators demonstrated that GW806742X could be a potential therapeutic agent for triple-negative breast cancer by targeting BCL-2.
[Biochemical Pharmacology]
Discovery of a Novel BCL-2 Inhibitor GW806742X for the Treatment of TNBC
Home Newsletters Mammary Cell News Discovery of a Novel BCL-2 Inhibitor GW806742X for the Treatment of TNBC
